30-Jul-2019 | Zion Market Research
Zion Market Research has published a new report titled “Allergy Immunotherapy Market by Treatment Type (SCIT and SLIT), by Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Drug Stores, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global allergy immunotherapy market was approximately USD 1.87 billion in 2018 and is expected to generate around USD 3.76 billion by 2025, at a CAGR of around 10.5% between 2019 and 2025.
Allergy immunotherapy is a type of immunotherapy where the person suffering from certain any kind of allergy is exposed to a particular type of allergen till the time his/her immune system modifies. The growing prevalence of allergies like allergy rhinitis, asthma, and food allergy, the introduction of various immunotherapy technologies, increasing R&D activities for developing immunotherapies against allergies, and rising awareness about the benefits of allergy immunotherapy are some the major factors fueling the global for allergy immunotherapy market.
Browse the full “Allergy Immunotherapy Market by Treatment Type (SCIT and SLIT), by Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Drug Stores, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/allergy-immunotherapy-market
The allergy immunotherapy market is fragmented on the basis of allergy type, treatment type, and distribution channel. Based on treatment type, the market includes subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). The SCIT segment is anticipated to dominate the market in the years ahead, owing to its effectiveness to treat various allergies like asthma. Additionally, SCIT is a treatment option that alters one’s immune system to prevent the development of other allergies.
By allergy type, the market for allergy immunotherapy is divided into asthma, venom allergy, food allergy, allergic rhinitis, and others. Allergic rhinitis is expected to dominate the market for allergy immunotherapy. According to the CDC, about 8% of the total population in the U.S. is suffering from allergy rhinitis. Thus, the growing prevalence of this allergy among adults as well as children is anticipated to fuel this segment’s growth in the upcoming years. Additionally, the asthma segment is expected to show a higher growth rate in the future, owing to the growing asthma prevalence worldwide.
The distribution channel segment of the allergy immunotherapy market comprises retail pharmacy and drug stores, online pharmacy, and hospital pharmacy. The hospital pharmacy segment is projected to dominate the market for allergy immunotherapy globally in the future, owing to the growing patient pool in hospitals worldwide for allergy treatment.
Europe is projected to dominate the allergy immunotherapy market, owing to the early introduction of immunotherapy treatments, an increasing geriatric population that is prone to different allergies, and rising number of supportive reimbursement policies by the government. The Asia Pacific allergy immunotherapy market is anticipated to show the highest growth rate in the upcoming years, owing to the rising investments and funding by government for R&D, increasing the number of people suffering from allergies, and growing awareness about the benefits of allergy immunotherapy to treat various allergies.
Some major players involved in the global allergy immunotherapy market are Abello, Aimmune Therapeutics, Stallergenes Greer, Allergy Therapeutics, Biomay, Merck, DBV Technologies, Circassia, HAL Allergy, and Anergis.
This report segments the global allergy immunotherapy market as follows:
Global Allergy Immunotherapy Market: Treatment Type Analysis
Global Allergy Immunotherapy Market: Allergy Type Analysis
Global Allergy Immunotherapy Market: Distribution Channel Analysis
Global Allergy Immunotherapy Market: Regional Analysis
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651